Priority ReviewThe nagging question for me is why Prometic chose to do the financing NOW. Why not wait until they know about FDA's decision regarding priority review/Pediatric Voucher? Would that not be better timing to get more $ per shares being offered? Perhaps management is anticipating a negative answer because too much time has gone by with no word from the FDA. I hope this is not the case.